Kalra Balkrishan — SEC insider filings
SEC reporting owner CIK 1768217. 31 insider filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2021-01-13 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 17 filings — 221,883 shares, $10,025,100 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: sale of 40,000 shares @ $43.35 ($1,734,000) in Genpact LTD, filed 2025-09-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Genpact LTD (G) | President and CEO, Director | 31 | — | 21 legs · 221,883 sh · $10,025,100 | 34 |
Insider filings — Kalra Balkrishan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Genpact LTD (G) | Sale (S): 10,000 @ $36.79 | EDGAR |
| 2026-03-12 | 4 | Genpact LTD (G) | Tax withholding (F): 13,893 @ $38.92 | EDGAR |
| 2026-03-05 | 4 | Genpact LTD (G) | Grant/award (A): 27,160 @ $0 · Option exercise (M): 2,800 @ $27.65 · Sale (S): 2,800 @ $40.77 · Option exercise (M): 2,800 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Genpact LTD (G) | Grant/award (A): 106,575 @ $0 | EDGAR |
| 2026-01-13 | 4 | Genpact LTD (G) | Tax withholding (F): 29,691 @ $48.24 | EDGAR |
| 2025-12-19 | 4 | Genpact LTD (G) | Grant/award (A): 125,130 @ $0 | EDGAR |
| 2025-09-15 | 4 | Genpact LTD (G) | Sale (S): 15,000 @ $43.39 · Option exercise (M): 40,000 @ $27.65 · Sale (S): 40,000 @ $43.35 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Genpact LTD (G) | Option exercise (M): 13,600 @ $27.65 · Sale (S): 13,600 @ $48.89 · Option exercise (M): 13,600 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Genpact LTD (G) | Grant/award (A): 78,782 @ $0 | EDGAR |
| 2025-01-14 | 4 | Genpact LTD (G) | Tax withholding (F): 36,461 @ $43.34 | EDGAR |
| 2024-12-17 | 4 | Genpact LTD (G) | Option exercise (M): 13,600 @ $27.65 · Sale (S): 13,600 @ $44.60 · Option exercise (M): 13,600 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | Genpact LTD (G) | Sale (S): 9,000 @ $46.40 | EDGAR |
| 2024-09-13 | 4 | Genpact LTD (G) | Sale (S): 7,000 @ $38.54 | EDGAR |
| 2024-03-15 | 4 | Genpact LTD (G) | Grant/award (A): 96,848 @ $0 | EDGAR |
| 2024-01-12 | 4 | Genpact LTD (G) | Tax withholding (F): 25,531 @ $34.27 | EDGAR |
| 2023-03-17 | 4 | Genpact LTD (G) | Grant/award (A): 40,249 @ $0 · Grant/award (A): 15,791 @ $0 | EDGAR |
| 2023-03-15 | 4 | Genpact LTD (G) | Option exercise (M): 22,280 @ $19.35 · Sale (S): 22,280 @ $44.40 · Option exercise (M): 22,280 (derivative) @ $0 | EDGAR |
| 2023-03-08 | 4 | Genpact LTD (G) | Option exercise (M): 17,446 @ $19.35 · Sale (S): 17,446 @ $47.31 · Option exercise (M): 2,554 @ $19.35 · Sale (S): 2,554 @ $47.50 · Option exercise (M): 17,446 (derivative) @ $0 · Option exercise (M): 2,554 (derivative) @ $0 | EDGAR |
| 2023-02-23 | 4 | Genpact LTD (G) | Option exercise (M): 25,000 @ $19.35 · Sale (S): 25,000 @ $47.99 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2023-01-12 | 4 | Genpact LTD (G) | Tax withholding (F): 9,441 @ $46.77 | EDGAR |
| 2022-09-09 | 4 | Genpact LTD (G) | Sale (S): 3,726 @ $46.37 · Sale (S): 7,000 @ $46.09 | EDGAR |
| 2022-09-07 | 4 | Genpact LTD (G) | Sale (S): 8,730 @ $47.40 | EDGAR |
| 2022-08-30 | 4 | Genpact LTD (G) | Sale (S): 10,000 @ $47.35 | EDGAR |
| 2022-03-09 | 4 | Genpact LTD (G) | Grant/award (A): 52,883 @ $0 | EDGAR |
| 2022-01-12 | 4 | Genpact LTD (G) | Tax withholding (F): 36,987 @ $52.12 · Grant/award (A): 103,412 (derivative) @ $0 | EDGAR |
| 2021-12-15 | 4 | Genpact LTD (G) | Sale (S): 5,000 @ $50.73 | EDGAR |
| 2021-09-16 | 4 | Genpact LTD (G) | Sale (S): 5,000 @ $50.18 | EDGAR |
| 2021-03-16 | 4 | Genpact LTD (G) | Grant/award (A): 24,445 @ $0 · Sale (S): 1,000 @ $42.80 | EDGAR |
| 2021-03-12 | 4 | Genpact LTD (G) | Sale (S): 2,147 @ $42.36 · Sale (S): 1,000 @ $42.72 | EDGAR |
| 2021-03-08 | 4 | Genpact LTD (G) | Grant/award (A): 187,724 (derivative) @ $0 | EDGAR |
| 2021-01-13 | 4 | Genpact LTD (G) | Tax withholding (F): 34,227 @ $41.50 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1768217 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs